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Abstract Physicists and medical doctors “speak” different
languages. Endovenous laser ablation (EVLA) is a good ex-
ample in which technology is essential to guide the doctor to
the final result: optimal treatment. However, for the doctor, it
is by far insufficient just to turn on the knobs of the laser. He
should understand what is going on in the varicose vein. On
the other hand, the physicist is usually not aware what prob-
lems the doctor finds on his road towards improving a new
technique. We have tried to bring both languages together in
the special on Ins and outs of endovenous laser ablation
published in this issue of Lasers in Medical Science. The 13
articles include endovenous related clinical (de Roos 2014;
Kockaert and Nijsten 2014; van den Bos and Proebstle 2014)
and socioeconomical articles (Kelleher et al 2014), the first
paper on the molecular pathophysiologic mechanisms (Heger
et al 2014), fiber tips (Stokbroekx et al 2014), the future of
EVLA (Rabe 2014), a review of EVLAwith some important
issues for debate (Malskat et al 2014), an excellent paper on
transcutaneous laser therapies of spider and small varicose
veins (Meesters et al 2014), as well as several scientific
modeling articles, varying from a mathematical model of
EVLA that includes the carbonized blood layer on the fiber
tip (van Ruijven et al 2014) and its application to the simula-
tion of clinical conditions (Poluektova et al 2014) via exper-
imental measurements of temperature profiles in response to
EVLA, radiofrequency waves, and steam injections (Malskat
et al 2014) to a literature review and novel physics approach of
the absorption and particularly scattering properties of whole
blood also including the infrared wavelengths used by EVLA
(Bosschaart et al 2014). The aim of our afterthoughts, the 14th
article in this special, is to try to amalgamate the clinical and
physical contents of these contributions, providing the reader
with the bridge that overlaps these different backgrounds.
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Introduction
Lasers are used in medicine since the late 1960s for the
treatment of port wine stains, so it was an excellent but also
logical idea to bring laser light into blood vessels. Seldinger
already demonstrated years before the access to blood ves-
sels for selective angiography [14]. The capillaries of vas-
cular skin malformations are too thin to work out this
concept of intracapillary laser treatment. However, arteries
as well as varicose veins, the latter with diameters of 3 to
over 20 mm for the incompetent greater saphenous vein
(GSV), are easy to access through a puncture in the skin and
wide enough to introduce a fiber catheter. In the 1980s,
laser angioplasty developed aimed to open up stenosed or
obliterated peripheral and coronary arteries [15, 16]. Sub-
sequently, in the late 1990s, the phlebologic community
was ready to apply laser light in varicose veins, albeit
now aimed to permanently obliterate the vein, stimulated
by a huge amount of varicose vein patients who were
waiting for a good alternative to the nearly 100 years old
stripping operation [17]. In contrast to the development of
drugs, where very strict regulations exist for a full devel-
opment trajectory, in surgery this is not required for tech-
nological innovations. So, the first laser treatment in a
varicose vein was performed in Spain in January 1998
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[18]. The laser catheter and fiber, and even a small endo-
scope, were introduced in the GSV; the laser was turned on
and the fiber slowly pulled back with excellent results. The
first laser was chosen because of its easy access, a diode
laser with a wavelength of 810 nm which is absorbed by the
hemoglobin content of the blood. It quickly turned out that
intravascular coagulation of the varicose vein by laser light
was patient friendly mainly due to the absence of general
anesthesia and highly effective. As it is a daycare proce-
dure, laser ablation was significantly cheaper than the clas-
sical stripping operation. Another technique developed in
dermatology by Jeffrey Klein for liposuction is the tumes-
cent anesthesia [19]. The introduction of Klein's solution
into the saphenous compartment provides anesthesia as
well as compression by the tumescent fluid, thus, also a
reduction of the vein diameter.
So, at the start of this millennium, several ideas and tech-
nical possibilities came together and created the venous
endovascular laser procedure. Looking back, it is still amazing
to observe the rapid evolution of this technique, now known as
endovascular laser ablation (EVLA), even though it was with-
out much, if any, knowledge of the processes which are going
on during and after the treatment.
Just like in the nineteenth century when every self-
respecting gynecologist had developed its own forceps for
complicated deliveries, phlebologists started to change the
laser probe, wavelength, laser power, and pullback velocity.
At the time that insurance companies already began to
refund EVLA procedures to their clients, some phlebologists
woke up. Among them was Thomas Proebstle, a German
dermatologist with a previous Masters in Physics [20, 21].
Many theories were subsequently launched to explain the
effectiveness of EVLA. The next step came also from a
clinician. Renate van den Bos, dermatologist in Rotterdam,
performed a meta-analysis in which she identified that the
available clinical data showed EVLA to be superior to surgery
and foam sclerotherapy [22]. In her group, studies were started
to explain the effects of heat conduction and to investigate the
consequences of coagulation of blood and subsequent carbon-
ization around the laser tip [23]. The Duplex ultrasound ob-
servation of bubbles in front of the laser tip turned out to be
steam bubbles which play a major role in the (convective)
transfer of heat to the luminal surroundings, including the vein
wall, suggested to behave comparable to the industrial model
of heat transport in heat pipes [20, 24, 25]. All these observa-
tions suggested that heat development and heat transport from
the source (laser light emitted out of the fiber) to the sink
(vessel wall) are an essential part of the clinical success of
EVLA. Nevertheless, the exact mechanisms of heat transport
which take place at the laser fiber tip and propagate through
the blood to the vessel wall still remained incompletely un-
derstood, which stimulated teams of clinicians and physicists
to join forces in combined projects trying to unravel the
secrets behind EVLA. Unfortunately, the number of such
teams active in EVLA remained limited [24–27].
It is not surprising therefore that the level of phlebology-
related physics was seriously criticized in the review of EVLA
in this issue [8], and it was hypothesized that lack of aware-
ness of this problem stimulated the unsubstantiated promotion
of new laser wavelengths for EVLA procedures. The two
examples used to demonstrate this convincement were the
suggested superiority of water over hemoglobin as EVLA
absorption targets, and the suggested importance and wide-
spread use of Joules per centimeter vein length, termed linear
endovenous energy density (LEED), aimed to characterize the
technical parameters of EVLA therapy so the procedure used
can be exactly duplicated if needed.
Our afterthoughts will cover the five currently proposed
mechanisms of EVLA efficacy, the irrelevance of water versus
hemoglobin absorption targeting, the uselessness of reporting
Joules per centimeter (LEED), the value of computational
modeling, and the timing of randomized controlled trials
(RCTs).
The five proposed mechanisms of action for EVLA
Five mechanisms have now been identified that at least
theoretically contribute to the efficacy of EVLA. The fifth
is a novel identified mechanism in this issue [5]. The first
four are the long-term consented thermal laser–tissue inter-
action mechanisms that cause the temperature of the vein
wall to increase, the assumed thermal key mechanism of
EVLA efficacy. First, direct contact between fiber tip and
vein wall [28]. Second, thermal interactions between the
laser light emitted out of the fiber tip and the vein wall. This
mechanism has two components: (a) direct absorption by
the vein wall of the light scattered by the blood that reaches
the wall, leading to an increased vein wall temperature and
(b) heating up the blood surrounding the fiber tip by direct
laser light absorption which causes heat flows to conduct
towards the wall and, upon arrival, produce an increased
wall temperature. In phlebology, only mechanism (a) was
considered; however, we showed in this issue that (b)
actually dominates over (a) [11]. Neglecting part (b) direct-
ed the whole EVLA field into the presumed but unproven
greatness of the water absorption wavelengths. Third, the
effects of steam bubbles, which were touted but not proven
to be the main EVLA mechanism [20, 24], including the
additional suggestion that the vein acts comparable to an
industrial heat pipe [25], and fourth, the effects of the
carbonized blood layer glued on the fiber tip. This mecha-
nism was widely known for many years to result from
switching on the laser while its fiber was embedded in the
blood [29]. Because the black layer strongly absorbs the
emitted light, it becomes exceedingly hot, around 1,000 °C,
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and causes damage or even melting of the tip [24]. The
consequential heat flow from the hot tip towards the vein
wall is capable of causing irreversible wall injury [23, 30].
Submission and publication of this long-known [29] but for
the EVLA clinical community apparently novel mechanism
provoked very strong phlebologic opposition in part be-
cause a black layer absorbs all wavelengths equally well,
thus suggesting virtually no influence of wavelength on
EVLA efficacy, which challenged the general accepted
belief at that time that water absorption based wavelengths
were the way to go, and consequently, therefore, also jeop-
ardized possible commercial interests.
The fifth is a novel mechanism for the first time identi-
fied in Heger's paper in this issue [5]. This fifth mechanism
is not based on thermal injury of the vein wall but on the
sequelae of thermal injury of blood , forming coagula with-
in the vein lumen. Despite doubts expressed in Heger's
paper on the likelihood of having sufficient blood volume
in an EVLA-treated vein to make this mechanism an im-
portant contributor to EVLA, we nevertheless include this
novel mechanism here in view of the fact that it contributes
at least theoretically to EVLA efficacy. This is in the spirit
of two other proposed mechanisms that may unlikely dom-
inate the efficacy of EVLA despite suggested importance,
i.e., direct laser light absorption by the vein wall [26] and
direct contact between fiber tip and vein wall [28].
Concerning the former, comparing zero with normal vein
wall absorption in our model simulations gave similar com-
puted wall temperatures, implying a limited importance of
direct vein wall light absorption [11]. Concerning the latter,
the small vein wall injury line of about 0.6 mm width
relative to the vein wall circumference of about 10 to
60 mm (diameters between 3 and 20 mm) was suggested
inadequate for vein obliteration [8]. Figure 1 visually sup-
ports this idea. So far, it is unknown to us whether, and if so
how, this fifth mechanism may provide opportunities for an
improved EVLA procedure or novel fiber tip design.
Interestingly, this wealth of five action mechanisms
perhaps implies that overtreatment occurs which, if true,
may explain the immense efficacy of any EVLA proce-
dure currently used, seemingly independent of anything,
i.e., wavelength, power, pullback velocity, and vein diam-
eter. More importantly, perhaps, it may also imply that
measures exist that retain the efficacy but reduce the pain
experienced during and/or following the procedure. An
interesting recent observation is that EVLA causes postop-
erative pain whereas endovenous steam ablation causes
pain during treatment [31]. Because both therapies use
the same tumescent anesthesia, this observation has cur-
rently no explanation. Thus, the issue of pain reduction
management at equal EVLA efficacy is not well under-
stood but is in our opinion a fascinating route to pursue in
the future.
The irrelevance of water versus hemoglobin absorption
targeting
Insufficient knowledge of the fact that laser–tissue interaction
mechanism (b), vein wall injury by heat flows originating
from the direct heated blood, also occurs in addition to heating
of the vein wall by direct light absorption, turned EVLA into a
turmoil of new EVLAwavelengths that use the water content
of the vein wall as the absorption target even to the extent of
touting 1,950 nm, indeed very strongly absorbed by water, as
a wavelength where EVLA may perhaps not need tumescent
anesthesia [32]. These predictions evidently neglected the
significant absorption by the water content of blood, well-
known to be about 60 %, for the photons traveling from the
fiber tip to the vein wall. It is perhaps interesting to speculate
what would have happened if such knowledge would have
been realized earlier. We hypothesize that this could have
prevented the repeated introduction of new wavelengths.
However, we also submit that this could have equally
prevented gaining the important knowledge of the effects of
the various wavelengths that is available to date, particularly
their small, if any, differences in EVLA efficacy.
The uselessness of linear endovenous energy density
(LEED)
LEED (Joules per centimeter vein length) was initiated in
2005 [33]. Malskat et al. [8] explain that the unit Joules per
centimeter originates from the ratio of laser power and pull-
back velocity, two essential elements to characterize the pro-
cedure and that, by taking this ratio, insufficient information
remains that allows exactly repeating the procedure.
An interesting question now is how it became possible that
phlebology-interested clinicians, as well as some physicists,
embraced a parameter that was aimed to characterize the
procedure but fails to do so without ever noticing. Our most
likely explanation is that clinicians, unlike physicists, have not
been thoroughly “programmed” in feeling the difference be-
tween laser energy and laser energy given per second, the
laser power. In Malkat's paper, an attempt is made to tutor the
reader on this difference [8].
The thermal efficacy of EVLA is clearly driven by the laser
power, not the laser energy [8, 10, 34], because the laser
action is virtually continuous (for laser pulses shorter than
about 0.1 s per pulse, it would have been the laser energy per
pulse). A clarifying example, perhaps somewhat ludicrous, is
to consider a 50 Joules/cm EVLA procedure. This LEED
produces an effective EVLA outcome if given as a 10 Watt
laser power and a 2 mm/sec pullback velocity, but it can
equally be given as 0.1 Watt and 0.02 mm/sec, here without
much hope of an effective EVLA procedure. Even 50 Joules/
cm can be given by extreme circumstances for EVLA
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procedures, e.g., as 10,000 Watt requiring 200 cm/sec pull-
back velocity (0.15 sec pullback for a 30-cm vein length) and
likely effective, or without any effect as 0.001 Watt and
0.0002 mm/sec (417 hours pullback for a 30 cm vein length!).
The latter examples obviously are clinically not very feasible,
but we hope they demonstrate the uselessness of using Joules
per centimeter because both still deliver the 50 Joules per cm
vein length!
Thus, using Joules per centimeter makes no sense, nei-
ther clinically nor scientifically, and the cleverly chosen
fancy name of linear endovenous energy density may have
promoted this “unit of phlebology” into its dubious status
of importance. The other interesting question now is wheth-
er the clinical use of LEED did hurt the field of EVLA?
Probably, it did and still does. When power and pullback
velocity are given in a paper, providing a number for LEED
is useless but at least the procedure can exactly be repeated
by other clinicians if wanted. However, it has also triggered
a lack of feeling the necessity of giving these essential
parameters which then precludes the possibility of repeti-
tion by others.
The value of computational modeling
The computational models currently available for EVLA [10,
34] assume the laser fiber to be exactly positioned in the
middle of a perfectly cylindrical venous tube, and emission
of the laser light power out of the fiber tip according to a point
source, which redistributes itself radially by a diffusion pro-
cess, governed by the blood's scattering and absorption prop-
erties at the wavelength considered. Our model also includes
the carbonized layer of blood [10] which absorbs about 45 %
of the laser power [30], the source for the very high computed
temperature of around 1,000 °C for this layer. The laser light
power per very small area, called the fluence rate (Watt per
area), available in the vein lumen, the vein wall and
perivenous tissue, can be absorbed according to their respec-
tive absorption coefficients, and the temporospatial tempera-
ture distribution follows from the solution of the bioheat
equation, e.g., see our review [8]. Although the models are
idealized, the majority of mechanistic concepts of EVLA are
correctly incorporated, with the exception of the thermal ef-
fects of steam bubbles and the wound healing effects of the
blood coagula on the vein wall. The value of modeling then is
its prediction of clinical behavior for varying EVLA parame-
ters. Such parameter variations, e.g., power, pullback velocity,
vein diameter, and tissue absorption (e.g., water versus hemo-
globin targeting wavelengths) cannot very easily be accounted
for during clinical or experimental procedures. However, al-
though the results can only be considered as simulations of an
idealized reality, the irrelevance of water versus hemoglobin
absorption targeting, the negligible contribution of direct vein
wall light absorption, the effects of a reduced vein diameter,
and the uselessness of Joules per centimeter follow perfectly
from these models.
The timing of RCTs: now or later?
RCTs are not only the basis of modern evidence-based med-
icine but also for providing guidelines and reimbursement by
insurance companies. There are RCTs available in literature in
which EVLA is compared with radiofrequency thermal abla-
tion, foam sclerotherapy, classical surgery, and recently
endovenous steam ablation. As laser parameters are widely
Fig. 1 Possible folding geometries of the (GSV) vein wall around the
EVLA fiber catheter following tumescent fluid injection for several vein
diameters. The catheter, shown as the inside rod, has an assumed diameter
of 3 mm, the (blue displayed) vein wall an assumed thickness of 1 mm.
The possible reduction in wall thickness due to the increased pressure by
the tumescent fluid has been neglected. We define FWDR as the ratio of
fiber diameter and inner vein wall circumference (π times the inner vein
diameter). From left to right: a fiber with 0.6 mm diameter, b vein with an
inner wall diameter of about 3 mm and FWDR=6.4 %; c inner wall
diameter of about 10 mm and FWDR=1.9 %; d inner wall diameter of
about 15 mm and FWDR=1.3 %; e inner wall diameter of about 20 mm
and FWDR=0.95%. For c and e , other folding arrangements are possible
(not shown). Inner vein wall diameters between 3 and 15 mm will always
include a combination of 1 and 3 wall thickness layers around the 3 mm
diameter catheter. Inner vein wall diameters between 15 and 27 mm
always include 3 and 5 wall thickness layers around the catheter. An
inner vein diameter of about 27 mm has five layers around the whole
catheter surface (not shown). Illustrations by Ron Slagter, Haarlem, The
Netherlands
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different, a comparison let alone a meta-analysis is virtually
impossible. Standardization of the EVLA technique thus is
essential for further RCTs.
One RCT that requires carrying out now is comparing the
EVLA efficacy of two (or more) laser wavelengths while
keeping all other parameters exactly the same. This study is
underway in Rotterdam, and the results are expected to be-
come available mid-2014. The issue of designing additional
RCTs likely is hampered by our lack of knowledge of the true
effects of steam bubbles. Here, we propose that the answer has
to await full incorporation of steam bubbles in future compu-
tational modeling, so predictions of their effects can be made
which may then stimulate the design of relevant RCTs to test
the predicted outcomes.
Chronic venous diseases and particularly varicose veins are
a socioeconomic burden [4]. Society could therefore expect
that with the development of new therapies for such a com-
mon problem, achieving an excellent cost-benefit ratio is
mandatory. Finally, the patients themselves has great influ-
ence. So, patient-related outcome parameters should support
the value of new treatments. In this respect, although EVLA is
very effective in the obliteration of incompetent veins, foam
sclerotherapy, endovenous radiofrequency ablation, and
endovenous steam ablation turn out to be better in patient-
related outcome parameters. As we mentioned before, it is
plausible that with the current laser settings used in EVLA
procedures, we overdose our target leading to vessel injuries,
extravasation of blood, and postoperative pain. The fact that
EVLA is so effective in the primary outcome parameter (oc-
clusion of the incompetent vein) may have prevented carrying
out dose finding studies, which are mandatory in pharmaco-
therapy. It is our belief that the side effects of EVLA can be
strongly reduced, and by this, an improvement of patient-
related outcome parameters can be achieved by a good dose
finding study concerning the laser settings.
Finally
The cooperation between physics and phlebology has opened
doors that one alone never could even have unlocked. Al-
though EVLA is just 16 years old [18, 28, 35, 36], we are still
not fully aware of all that happens during a procedure, but we
now at least have the duty to explain what currently is known
of this elegant and effective technique to those who perform
this treatment on a regular basis in their practice. To demystify
the superior influence of the chosen laser parameters, every-
body who performs EVLT should realize that the introduction
of laser light (power rather than energy) into the blood (main-
ly water and hemoglobin as absorbing chromphores) will
result in a reaction in which heat is essential, but it is just this
rise in temperature which makes the procedure difficult to
understand completely because clotting of blood and
carbonization on the fiber tip take place. A heat-induced blood
coagulum will be formed that behaves differently than a
“normal” thrombus. Nevertheless, it will release many active
substances which will interact with the vessel wall. Even in
case this vessel wall is not yet affected by heat, the active lytic
enzymes and other elements from the blood coagulum will
influence the vessel wall [5]. A spontaneous thrombosis in the
GSVusually recanalizes spontaneously too, leaving in the end
a patent vein. However, in EVLA, obliteration is the end stage
achieved by the combined action of thrombus formation and
heat conduction. Coagulum and/or thrombus formation during
treatment for varicose veins is not only unique for EVLA but
also for other thermal ablations such as by radiofrequency
waves and steam. Also, foam sclerotherapy forms a kind of
coagulum and sometimes even thrombus formation occurs.
Nevertheless, in EVLA, it is an essential part of the process
because a pure bloodless vessel is a utopia and intravenous
laser light is very effective in forming coagula, irrespective of
wavelength. In addition, when the laser is switched on a
coagulum will be formed around the fiber tip and will be
partly transformed into carbon by the extreme high tempera-
ture reached at the laser tip (>1,000 °C). Carbon is black and
consequently absorbs all EVLA laser wavelengths equally
well. Certainly, not all laser power will be absorbed by the
carbon layer, but from this moment on, EVLA has reduced its
possible wavelength dependent efficacy and strongly in-
creased the intraluminal production of heat.
In conclusion, the prognosis of an increasing incidence
of age-related varicose veins [7] stimulates us to extend
our knowledge of what is really going on during and after
EVLA, so there is a need for new research, clinical as
well as in the laboratory. Only then will we be able to
come up with a consented best therapy that includes not
only a very high success rate but also a strong reduction
or even absence of pain during as well as after EVLA. If
the already proven fruitful cooperation between doctor
and physicist continues, this already good therapy can
reach the status of excellence.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
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